JPRN-jRCT2051210183已完成1 期
A Single Dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-6194 in Healthy Japanese Participants
Tanaka Yoshiyuki0 个研究点目标入组 48 人开始时间: 2022年3月2日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 55age old（—）
- 性别
- Male
入选标准
- •Healthy Japanese male between the ages of 20 and 55 years with BMI within 18 to 25 kg/m2 inclusive and weight >=50 kg
排除标准
- •History of clinically significant abnormalities or diseases
研究者
相似试验
招募中
1 期
Single Dose Study of MK-2214 in Healthy Japanese ParticipantsAlzheimer's DiseaseJPRN-jRCT2031220627Tanaka Yoshiyuki48
进行中（未招募）
1 期
Single Dose Study of MK-2060 in Japanese Older Participants on Dialysisend-stage renal diseaseJPRN-jRCT2041230025Tanaka Yoshiyuki16
未知
1 期
A Phase 1, Repeat Dose Study to Evaluate the Safety, Tolerability, Biological Activity, and Pharmacokinetics of ND-L02-s0201 Injection in Japanese Subjects with Advanced Hepatic Fibrosis (METAVIR F3-4)Advanced Hepatic FibrosisJPRN-jRCT2080222907ITTO DENKO CORPORATIO9
已完成
不适用
A single dose clinical trial to study the safety of ART-I02 in patients with arthritisarthritis10003816NL-OMON45686Arthrogen B.V.12
撤回
不适用
A single dose clinical trial to study the safety of ART-I02 in patients with rheumatoid arthritis10003816rheumatoid arthritisNL-OMON43315Arthrogen B.V.15